CIP
MGNX icon

Chartwell Investment Partners’s MacroGenics MGNX Stock Holding History

Chartwell Investment Partners’s Portfolio MGNX Stock Details MGNX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q4 		– Sell
-279,469
Closed -$5.84M – 372
2014
Q3 		$5.84M Sell
279,469
-3,430
-1% -$70.9K 0.13% 241
2014
Q2 		$6.15M Buy
282,899
+37,689
+15% +$792K 0.13% 226
2014
Q1 		$6.82M Buy
+245,210
New +$8.66M 0.14% 223

Other funds holding MGNX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
BRC
Blue Ridge Capital New York $215M AUM
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
DFO
Duquesne Family Office New York $3.38B AUM 61.92% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
EAM
EverPoint Asset Management Stamford, Connecticut $5.38B AUM 21.45% 1-Year Est. Return

Chartwell Investment Partners's MGNX Position: Q4 2014 in Review

Chartwell Investment Partners sold out of MacroGenics (MGNX) in Q4 2014, closing a stake of 279,469 shares — an estimated $5.84M sold.

Chartwell Investment Partners first reported a position in MGNX in Q1 2014 and held it in 3 quarters. The position peaked at $6.82M in Q1 2014. 107 funds tracked by Wall St. Rank hold MGNX as of Q4 2014.

  • Chartwell Investment Partners reported no remaining MacroGenics position as of Q4 2014 after selling out during the quarter.
  • Chartwell Investment Partners sold 279,469 MacroGenics shares in Q4 2014, an estimated $5.84M.
  • Chartwell Investment Partners first reported a position in MacroGenics in Q1 2014 and held it in 3 quarters.
  • Chartwell Investment Partners's MacroGenics position peaked at $6.82M in Q1 2014.
  • 107 funds tracked by Wall St. Rank held MacroGenics as of Q4 2014.

Based on Chartwell Investment Partners's 13F filing for Q4 2014, filed 9 Feb 2015.